In accordance with the resolution of the Annual General Meeting on May 14th, 2024, the Chairman of the Board has contacted the company’s two largest shareholders or group of shareholders in terms of ...
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TSE: 6701), a leader in IT, network and ...